What question did this study set out to answer?

Evaluate the pharmacological properties, therapeutic spectrum, and clinical utility of adriamycin in cancer chemotherapy.

December 1, 1975JNCI Journal of the National Cancer InstituteOpen Access

Adriamycin—A Review

View Full Paper

Ask AI

Bookmark

Authors

SCStephen K. CarterMaxygen (United States)

Discussion

Member takes

Implication

Narrative review outlines the therapeutic efficacy and pharmacology of adriamycin across diverse malignancies, highlighting its role as a broad-spectrum chemotherapeutic.

Key Points

Evaluate the pharmacological properties, therapeutic spectrum, and clinical utility of adriamycin in cancer chemotherapy.
Narrative review analyzing preclinical data and clinical trial findings on adriamycin efficacy and pharmacokinetics across multiple tumor types.
Demonstrates broad-spectrum antitumor activity against solid tumors and hematologic malignancies.
Outlines clinical response rates, optimal administration schedules, and cumulative dose-dependent toxicities associated with anthracycline therapy.

Cite This Study

Stephen K. Carter (1975) studied this question.

synapsesocial.com/papers/6a7f423b290a50e19e6f3cd3 https://doi.org/10.1093/jnci/55.6.1265

Topics

Heart failure HFrEF treatment

View Full Paper

Ask AI

Bookmark

Implication

Narrative review outlines the therapeutic efficacy and pharmacology of adriamycin across diverse malignancies, highlighting its role as a broad-spectrum chemotherapeutic.

Adriamycin—A Review

Discussion

Member takes

Implication

Key Points

Cite This Study

Topics

Adriamycin—A Review

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Topics

Also Consider